In conversation with... Beau Ances

from Listen to The Lancet Neurology · host The Lancet

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.

Episode metadata supplied by the publisher feed · Published Dec 14, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Beau Ances

0:00 11:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Neurology?

This episode is 11 minutes long.

When was this Listen to The Lancet Neurology episode published?

This episode was published on December 14, 2022.

Can I download this Listen to The Lancet Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!